Lower trial participation by culturally and linguistically diverse (CALD) cancer patients is largely due to language barriers.

Allan 'Ben' SmithMeera AgarGeoff DelaneyJoseph DescallarKelsey Dobell-BrownMelissa GrandJennifer AungPinky PatelNasreen KaadanAfaf Girgis

Published in: Asia-Pacific journal of clinical oncology (2017)

Limited English proficiency seems particularly unfavorable to trial participation. Development and evaluation of strategies to overcome language barriers (e.g. simplified and translated multimedia participant information materials) is needed.

Keyphrases

phase iii
study protocol
phase ii
physical activity
autism spectrum disorder
clinical trial
open label
randomized controlled trial
health information
social media
double blind